November 25, 2019 / 6:15 AM / 16 days ago

BRIEF-FDA Grants Priority Review To Roche’S Risdiplam For Spinal Muscular Atrophy

Roche Holding AG:

* FDA GRANTS PRIORITY REVIEW TO ROCHE’S RISDIPLAM FOR SPINAL MUSCULAR ATROPHY

* FDA GRANTS PRIORITY REVIEW TO ROCHE’S RISDIPLAM FOR SPINAL MUSCULAR ATROPHY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below